Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date-Reference-Cited by-同舟云学术

Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date

Published:2020-08-10 Issue:15 Volume:80 Page:1509-1524
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Chalhoub Reda M.^ORCID,Kalivas Peter W.^ORCID

Funder

National Institute on Drug Abuse

National Institute of Drug Abuse

Veterans Administration

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-020-01373-1.pdf

Reference176 articles.

1. Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–73. https://doi.org/10.1016/S2215-0366(16)00104-8.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington: American Pyschiatric Publishing; 2013.

3. Hser Y-I, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503–8. https://doi.org/10.1001/archpsyc.58.5.503.

4. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. NSDUH Series H-54. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019.

5. Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry. 2016;173(1):18–26. https://doi.org/10.1176/appi.ajp.2015.15020262.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal;Psychopharmacology;2024-09-10

2. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder;Addiction Science & Clinical Practice;2024-07-27

3. Neurocognitive performance of patients undergoing intravenous versus oral opioid agonist treatment: a prospective multicenter study on three-month treatment effects;Frontiers in Psychiatry;2024-07-23

4. Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction;ACS Pharmacology & Translational Science;2024-05-27

5. Treadmill exercise training inhibits morphine CPP by reversing morphine effects on GABA neurotransmission in D2-MSNs of the accumbens-pallidal pathway in male mice;Neuropsychopharmacology;2024-05-07